Josep Lluís Parra

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

Violeta Serra, Ben Markman, Maurizio Scaltriti et al. · Cancer Research · 2008 · 795 citations · Full text

The Mnks Are Novel Components in the Control of TNFα Biosynthesis and Phosphorylate and Regulate hnRNP A1

Maria Buxadé, Josep Lluís Parra, Simon Rousseau et al. · Immunity · 2005 · 222 citations · Full text

Transcriptional Regulation, Tnfα Biosynthesis, Signal Transduction +13

Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor

Maurizio Scaltriti, Sarat Chandarlapaty, Ludmila Prudkin et al. · Clinical Cancer Research · 2010 · 150 citations · Full text

The N and C Termini of the Splice Variants of the Human Mitogen-Activated Protein Kinase-Interacting Kinase Mnk2 Determine Activity and Localization

Gert C. Scheper, Josep Lluís Parra, Mary Ann Wilson et al. · Molecular and Cellular Biology · 2003 · 109 citations · Full text

Nuclear Import, Molecular Regulation, Molecular Biology +17

High HER2 Expression Correlates with Response to the Combination of Lapatinib and Trastuzumab

Maurizio Scaltriti, Paolo Nucíforo, Ian Bradbury et al. · Clinical Cancer Research · 2014 · 102 citations · Full text